Total Payments
$1,264
2024 Payments
$289.46
Companies
11
Transactions
44
Payment Breakdown by Category
Food & Beverage$1,264 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,264 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $490.24 | 12 | $0 (2024) |
| Eisai Inc. | $187.54 | 4 | $0 (2023) |
| Clovis Oncology, Inc. | $147.65 | 9 | $0 (2022) |
| Merck Sharp & Dohme LLC | $142.27 | 6 | $0 (2024) |
| Seagen Inc. | $82.40 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $56.68 | 2 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $49.14 | 2 | $0 (2024) |
| ABBVIE INC. | $32.55 | 2 | $0 (2024) |
| Celltrion USA Inc. | $31.47 | 1 | $0 (2023) |
| Amneal Pharmaceuticals LLC | $26.50 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $289.46 | 12 | Merck Sharp & Dohme LLC ($142.27) |
| 2023 | $394.11 | 12 | Eisai Inc. ($117.92) |
| 2022 | $318.13 | 12 | AstraZeneca Pharmaceuticals LP ($179.37) |
| 2021 | $262.74 | 8 | AstraZeneca Pharmaceuticals LP ($142.93) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: Oncology | ||||||
| 06/06/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: ONCOLOGY | ||||||
| 04/22/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $34.01 | General |
| Category: Oncology | ||||||
| 04/11/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: ONCOLOGY | ||||||
| 02/19/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2024 | ImmunoGen, Inc. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2023 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Oncology | ||||||
| 11/17/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2023 | Amneal Pharmaceuticals LLC | AVASTIN (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Oncology | ||||||
| 08/16/2023 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: ONCOLOGY | ||||||
| 07/20/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: ONCOLOGY | ||||||
| 07/06/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Oncology | ||||||
| 04/27/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Oncology | ||||||
| 04/06/2023 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Oncology | ||||||
| 03/07/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: ONCOLOGY | ||||||
| 02/02/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Oncology | ||||||
| 01/17/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $117.92 | General |
| Category: Oncology | ||||||
| 12/15/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Oncology | ||||||
About Margaret Gregus
Margaret Gregus is a Oncology healthcare provider based in Hinsdale, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2020. The National Provider Identifier (NPI) number assigned to this provider is 1346870177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Margaret Gregus has received a total of $1,264 in payments from pharmaceutical and medical device companies, with $289.46 received in 2024. These payments were reported across 44 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,264).
Ad
Practice Information
- Specialty Oncology
- Location Hinsdale, IL
- Active Since 01/21/2020
- Last Updated 01/21/2020
- Taxonomy Code 364SX0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346870177
Products in Payments
- LYNPARZA (Drug) $490.24
- Lenvima (Drug) $187.54
- Rubraca (Drug) $147.65
- KEYTRUDA (Biological) $95.72
- TIVDAK (Biological) $82.40
- ZEJULA (Drug) $56.68
- ELAHERE (Drug) $50.55
- MYRISK (Device) $49.14
- LYNPARZA (Biological) $46.55
- VEGZELMA (Biological) $31.47
- AVASTIN (Drug) $26.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.